-
Vericiguat
Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika) Vericiguat ʻAʻohe puʻuwai Bayer a me MSD Mei. 24, 2031 -
Abrocitinib
Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika) Abrocitinib ʻO ka Dermatitis Atopic Pfizer Feb.11, 2034 -
Rimegepant
Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika) Rimegepant ʻO ka migraine headache Biohaven Feb. 22, 2031 -
Elagolix 834153-87-6
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP ElagolixCAS:834153-87-6 Endometriosis I-Hale -
Relugolix 737789-87-6
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Ribociclib CAS: 737789-87-6 Atineoplastic I-Hale -
Venetoclax 1257044-40-8
Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika) Venetoclax 1257044-40-8 CLL Abbvie Iun.27,2031 -
Velpatasvir(PVP)
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Velpatasvir(PVP) HCV I-Hale √ -
ʻO Thalidomide
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP ʻO Thalidomide Laau oncology USP/EP -
Ticagrelor
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Ticagrelor ʻO ka lāʻau anticoagulant I-Hale 28984 √ -
Tofacitnib Citrate
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Tofacitnib Citrate Rheumatoid arthritis I-Hale -
Sugammadex Sodium
Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP Sugammadex Sodium Paʻa neuromuscular I-Hale